TY  - JOUR
AU  - Majem, M
AU  - Juan, O
AU  - Insa, A
AU  - Reguart, N
AU  - Trigo, J M
AU  - Carcereny, E
AU  - García-Campelo, R
AU  - García, Y
AU  - Guirado, M
AU  - Provencio, M
PY  - 2018
DO  - 10.1007/s12094-018-1978-1
UR  - http://hdl.handle.net/10668/13197
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper...
LA  - en
KW  - Chemotherapy
KW  - Immunotherapy
KW  - NSCLC
KW  - Radiotherapy
KW  - Targeted therapies
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - Disease Management
KW  - Humans
KW  - Lung Neoplasms
KW  - Practice Guidelines as Topic
KW  - Prognosis
KW  - Societies, Medical
TI  - SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).
TY  - research article
VL  - 21
ER  -